Smoking-related factors, such as higher mutational burden and PD-L1 expression, may contribute to increased ICI sensitivity in BRAF mutant NSCLC, similar to KRAS mutations [82, 83]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.